Inventor
Stephen T. Wrobleski
Inventor
Whitehouse Station, NJ, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations42%
C07BGeneral methods of organic chemistry6%
A61KPreparations for medical, dental or toiletry purposes5%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
11,021,462Sulfone pyridine alkyl amide-substituted heteroaryl compounds202111,021,475Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses202110,781,215Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNa responses2020RE047929Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNa responses202010,526,321Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses202010,308,652Tricyclic heterocyclic compounds useful as inhibitors of TNF201910,112,944Heterocyclic compounds useful as inhibitors of TNF201810,000,480Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses20189,987,266Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNa responses20189,663,467'Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses'20179,540,333'Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα'20179,505,748'Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses'20169,315,494'Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses'20169,221,826'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20158,987,268'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20158,921,368'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20148,404,689'Heterocyclic amide compounds useful as kinase inhibitors'20138,309,571'Heterobicyclic compounds useful as kinase inhibitors'20128,044,040'N-heterocyclic inhibitors of TNF-alpha expression'20117,943,658'Indole indane amide compounds useful as CB2 agonists and method'20117,943,617'Heterobicyclic compounds useful as kinase inhibitors'20117,935,696'Heterocyclic amide compounds useful as kinase inhibitors'20117,923,556'Phenyl-substituted pyrimidine compounds useful as kinase inhibitors'20117,759,343'Pyrrolo-triazine aniline compounds useful as kinase inhibitors'20107,723,336'Fused heterocyclic compounds useful as kinase modulators'20107,642,257'Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors'20107,605,273'Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors'20097,592,338'Pyrazole-amine compounds useful as kinase inhibitors'20097,534,881'Method for preparing pyrrolotriazine compounds'20097,479,495'N-heterocyclic inhibitors of TNF-α expression'20097,462,616'Pyrrolo-triazine aniline compounds useful as kinase inhibitors'20087,419,978'Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors'20087,414,056'Pyrazole-amide compounds useful as kinase inhibitors'20087,396,935'Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors'20087,390,810'Pyrazole-amine compounds useful as kinase inhibitors'20087,388,009'Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors'20087,253,170'Pyrazole-amine compounds useful as kinase inhibitors'20077,253,174'N-heterocyclic inhibitors of TNF-α expression'20077,253,167'Tricyclic-heteroaryl compounds useful as kinase inhibitors'20077,211,666'Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors'20077,160,883'Pyrrolo-triazine aniline compounds useful as kinase inhibitors'20077,151,113'Pyrazole-amine compounds useful as kinase inhibitors'20067,034,151'Process for preparing pyrrolotriazine kinase inhibitors'20066,906,067'N-heterocyclic inhibitors of TNF-α expression'20056,867,300'Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors'20056,670,357'Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors'20036,653,304'Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2021Patents assigned to BRISTOL MYERS SQUIBB CO (45)· patent assignee history
2003–2013Based in Whitehouse Station, NJ, US· patent location history
2008Based in Princeton, NJ, US· patent location history
2012–2015Patents assigned to WROBLESKI STEPHEN T (5)· patent assignee history
2013–2015Patents assigned to HYNES JOHN (4)· patent assignee history
2013–2015Patents assigned to LIN SHUQUN (4)· patent assignee history
2013–2015Patents assigned to DAS JAGABANDHU (3)· patent assignee history
2014–2021Based in Flemington, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 45 | 2003–2021 |
| WROBLESKI STEPHEN Tself | 5 | 2012–2015 |
| HYNES JOHN | 4 | 2013–2015 |
| LIN SHUQUN | 4 | 2013–2015 |
| DAS JAGABANDHU | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Whitehouse Station, New Jersey, US | 30 | 2003–2013 |
| Flemington, New Jersey, US | 16 | 2014–2021 |
| Princeton, New Jersey, US | 1 | 2008 |